Matches in SemOpenAlex for { <https://semopenalex.org/work/W4254134920> ?p ?o ?g. }
Showing items 1 to 68 of
68
with 100 items per page.
- W4254134920 endingPage "8" @default.
- W4254134920 startingPage "5" @default.
- W4254134920 abstract "Non-small cell lung cancer (NSCLC) continues be one of the most frequent oncological diseases both in incidence and mortality. Over the past ten years, due to the targeted and immunotherapy, significant success has been achieved in the treatment of metastatic forms NSCLC, but until recently, approaches to the treatment of earlier stages of NSCLC have remained unchanged. So, the standard treatment of locally-advanced unresectable NSCLC remained chemo-radiation (concurrent or sequential). The first study that has demonstrated the possibility of improving treatment results (including long term results) using an innovative approach from combination of durvalumab immunotherapy with chemo-radiation therapy (CRT) as an integrated treatment complex in this category of patients, has become the PACIFIC study. In Russia, durvalum ab was registered in July 2019 for using in patients with locally advanced NSCLC who have not progressed after CRT, so the experience of its administration in real clinical practice is still small. In this article, we summarized our local experience with durvalumab treatment in seven patients and presented more detailed one of the clinical cases. A patient with stage III unresectable NSCLC began receiving durvalumab therapy in October 2018, 2 months after completing a course of sequential CRT. Currently, after 12 months of therapy, the stabilization of the disease persists, the patient continues treatment." @default.
- W4254134920 created "2022-05-12" @default.
- W4254134920 creator A5005594228 @default.
- W4254134920 creator A5021339929 @default.
- W4254134920 creator A5046981423 @default.
- W4254134920 creator A5060753407 @default.
- W4254134920 date "2019-11-22" @default.
- W4254134920 modified "2023-10-01" @default.
- W4254134920 title "Experience of using durvalumab in unresectable stage III non-small cell lung cancer in Irkutsk Region" @default.
- W4254134920 cites W2110469369 @default.
- W4254134920 cites W2149089484 @default.
- W4254134920 cites W2263280562 @default.
- W4254134920 cites W2893824814 @default.
- W4254134920 doi "https://doi.org/10.33667/2078-5631-2019-3-28(403)-5-8" @default.
- W4254134920 hasPublicationYear "2019" @default.
- W4254134920 type Work @default.
- W4254134920 citedByCount "1" @default.
- W4254134920 countsByYear W42541349202022 @default.
- W4254134920 crossrefType "journal-article" @default.
- W4254134920 hasAuthorship W4254134920A5005594228 @default.
- W4254134920 hasAuthorship W4254134920A5021339929 @default.
- W4254134920 hasAuthorship W4254134920A5046981423 @default.
- W4254134920 hasAuthorship W4254134920A5060753407 @default.
- W4254134920 hasBestOaLocation W42541349201 @default.
- W4254134920 hasConcept C121608353 @default.
- W4254134920 hasConcept C126322002 @default.
- W4254134920 hasConcept C143998085 @default.
- W4254134920 hasConcept C146357865 @default.
- W4254134920 hasConcept C151730666 @default.
- W4254134920 hasConcept C2776256026 @default.
- W4254134920 hasConcept C2777701055 @default.
- W4254134920 hasConcept C2777742743 @default.
- W4254134920 hasConcept C2780030458 @default.
- W4254134920 hasConcept C509974204 @default.
- W4254134920 hasConcept C71924100 @default.
- W4254134920 hasConcept C86803240 @default.
- W4254134920 hasConceptScore W4254134920C121608353 @default.
- W4254134920 hasConceptScore W4254134920C126322002 @default.
- W4254134920 hasConceptScore W4254134920C143998085 @default.
- W4254134920 hasConceptScore W4254134920C146357865 @default.
- W4254134920 hasConceptScore W4254134920C151730666 @default.
- W4254134920 hasConceptScore W4254134920C2776256026 @default.
- W4254134920 hasConceptScore W4254134920C2777701055 @default.
- W4254134920 hasConceptScore W4254134920C2777742743 @default.
- W4254134920 hasConceptScore W4254134920C2780030458 @default.
- W4254134920 hasConceptScore W4254134920C509974204 @default.
- W4254134920 hasConceptScore W4254134920C71924100 @default.
- W4254134920 hasConceptScore W4254134920C86803240 @default.
- W4254134920 hasIssue "28" @default.
- W4254134920 hasLocation W42541349201 @default.
- W4254134920 hasOpenAccess W4254134920 @default.
- W4254134920 hasPrimaryLocation W42541349201 @default.
- W4254134920 hasRelatedWork W2009226744 @default.
- W4254134920 hasRelatedWork W2277416945 @default.
- W4254134920 hasRelatedWork W2395953112 @default.
- W4254134920 hasRelatedWork W2923986778 @default.
- W4254134920 hasRelatedWork W3115829157 @default.
- W4254134920 hasRelatedWork W3137670083 @default.
- W4254134920 hasRelatedWork W3171615116 @default.
- W4254134920 hasRelatedWork W3175383630 @default.
- W4254134920 hasRelatedWork W3217115064 @default.
- W4254134920 hasRelatedWork W4220655021 @default.
- W4254134920 hasVolume "3" @default.
- W4254134920 isParatext "false" @default.
- W4254134920 isRetracted "false" @default.
- W4254134920 workType "article" @default.